Literature DB >> 27068248

Graft preservation solutions in cardiovascular surgery.

Bernhard Winkler1, David Reineke2, Paul Philip Heinisch2, Florian Schönhoff2, Christoph Huber2, Alexander Kadner2, Lars Englberger2, Thierry Carrel2.   

Abstract

Vein grafts are still the most commonly used graft material in cardiovascular surgery and much effort has been spent in recent years on investigating the optimal harvesting technique. One other related topic of similar importance remained more or less an incidental one. The storage solutions of vein grafts following procurement and prior to implantation are, despite their assumed impact, a relatively neglected theme. There is no doubt that the endothelium plays a key role in long-term patency of vein grafts, but the effects of the different storage solutions on the endothelium remain unclear : In a review of the literature, we could find 20 specific papers that addressed the question, of which the currently available preservation solutions are superior, harmless, damaging or ineffective. The focus lies on saline and autologous whole blood. Besides these two storage media, novel or alternative solutions have been investigated with surprising findings. In addition, a few words will be spent on potential alternatives and novel solutions on the market. As there is currently no randomized clinical trial regarding saline versus autologous whole blood available, this review compares all previous studies and methods of analysis to provide a certain level of evidence on this topic. In summary, saline has negative effects on the endothelial layers and therefore may compromise graft patency. Related factors, such as distension pressure, may outbalance the initial benefit of autologous whole blood or storage solutions and intensify the harmful effects of warm saline. In addition, there is no uniform consent on the superiority of autologous whole blood for vein graft storage. This may open the door to alternatives such as the University of Wisconsin solution or one of the specific designed storage solutions like TiProtec™ or Somaluthion™. Whether these preservation solutions are superior or advantageous remains the subject of further studies.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Coronary artery bypass surgery; Saphenous vein graft; Storage solutions

Mesh:

Substances:

Year:  2016        PMID: 27068248     DOI: 10.1093/icvts/ivw056

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

Review 1.  Saphenous vein grafts in contemporary coronary artery bypass graft surgery.

Authors:  Etem Caliskan; Domingos Ramos de Souza; Andreas Böning; Oliver J Liakopoulos; Yeong-Hoon Choi; John Pepper; C Michael Gibson; Louis P Perrault; Randall K Wolf; Ki-Bong Kim; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2019-08-27       Impact factor: 32.419

2.  Vascular surgical stretch injury leads to activation of P2X7 receptors and impaired endothelial function.

Authors:  Padmini Komalavilas; Weifeng Luo; Christy M Guth; Olukemi Jolayemi; Rachel I Bartelson; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

3.  Quercetin Relieves the Excised Great Saphenous Vein Oxidative Damage and Inflammatory Reaction.

Authors:  Yunpeng Bai; Qingliang Chen; Xiaolong Zhu; Nan Jiang; Ximing Li; Zhigang Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-31       Impact factor: 2.629

4.  Limiting Injury During Saphenous Vein Graft Preparation For Coronary Arterial Bypass Prevents Metabolic Decompensation.

Authors:  Joyce Cheung-Flynn; Jun Song; Igor Voskresensky; Eric S Wise; Yapu Liu; Yanhua Xiong; Susan S Eagle; Colleen M Brophy; C Robb Flynn
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

5.  Do storage solutions protect endothelial function of arterialized vein graft in an experimental rat model?

Authors:  Olivier Fouquet; Jean-David Blossier; Simon Dang Van; Pauline Robert; Agnès Barbelivien; Frédéric Pinaud; Patrice Binuani; Maroua Eid; Daniel Henrion; Christophe Baufreton; Laurent Loufrani
Journal:  J Cardiothorac Surg       Date:  2020-02-10       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.